Back to all companies

Immunai

New York, United States; Ramat Gan, Israel · Health tech / Drug discovery

Latest reported funding

$215M Series B

Funding source
Company website

Immunai develops computational tools to support drug discovery and development. It has teams in the United States, Israel and Europe. Viola reported its $215 million Series B in October 2021.

Submit a funding round

Hiring? Add a featured job

Open roles at Immunai

10 roles
RoleDepartmentLocationTypeDate posted
AI Infrastructure EngineerSoftware EngineeringRamat GanFirst seen 12 Nov 2026Apply
Associate Scientist, Molecular ProfilingMolecular ProfilingNew York CityFull-timeFirst seen 12 Nov 2026Apply
Computational Biologist II, External CollaborationsExternal CollaborationsNew York CityFull-timeFirst seen 12 Nov 2026Apply
Data Infrastructure Team LeadSoftware EngineeringRamat GanFirst seen 12 Nov 2026Apply
Director of AI ProductProductRamat GanFull-timeFirst seen 12 Nov 2026Apply
Head of AIDeep AnalyticsRamat GanFirst seen 12 Nov 2026Apply
Senior AI EngineerDeep AnalyticsRamat GanFirst seen 12 Nov 2026Apply
Senior I / Senior II Computational Biologist, External CollaborationsExternal CollaborationsNew York CityFull-timeFirst seen 12 Nov 2026Apply
Senior Scientist / Scientist II, Systems ImmunologyExternal CollaborationsNew York CityFull-timeFirst seen 12 Nov 2026Apply
Staff Architect, Data & AI InfraSoftware EngineeringRamat GanFirst seen 12 Nov 2026Apply

Role and seniority are inferred from job titles and departments. Posting dates come from employers where available; “First seen” means first discovered by IsraelVC. Undated roles sort last.

Visit company careers site

Last successful check: 12 Nov 2026, 16:44 UTC. Applications are handled by the employer.